MEF2D anticorps (N-Term)

N° du produit ABIN966557

Détail du produit anti-MEF2D anticorps

Antigène: MEF2D (Myocyte Enhancer Factor 2D (MEF2D))

Épitope: N-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MEF2D est non-conjugé

Application: Immunohistochemistry (IHC)

Immunogène: Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to N-terminal residues of human MEF2D (Myocyte-specific enhancer factor 2D)

Information d'application

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Références pour anticorps anti-MEF2D (ABIN966557)

Okamoto, Li, Ju, Scholzke, Mathews, Cui, Salvesen, Bossy-Wetzel, Lipton: "Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 6, pp. 3974-9, (2002) (PubMed).

Kato, Zhao, Morikawa, Sugiyama, Chakravortty, Koide, Yoshida, Tapping, Yang, Yokochi, Lee: "Big mitogen-activated kinase regulates multiple members of the MEF2 protein family." dans: The Journal of biological chemistry, Vol. 275, Issue 24, pp. 18534-40, (2000) (PubMed).

Zhao, New, Kravchenko, Kato, Gram, di Padova, Olson, Ulevitch, Han: "Regulation of the MEF2 family of transcription factors by p38." dans: Molecular and cellular biology, Vol. 19, Issue 1, pp. 21-30, (1999) (PubMed).

Breitbart, Liang, Smoot, Laheru, Mahdavi, Nadal-Ginard: "A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage." dans: Development (Cambridge, England), Vol. 118, Issue 4, pp. 1095-106, (1994) (PubMed).

Détails sur MEF2D

Antigène: MEF2D (Myocyte Enhancer Factor 2D (MEF2D))

Autre désignation: MEF2D (MEF2D Produits)

Synonymes: anticorps sl1, anticorps sl-1, anticorps XMEF2D, anticorps MGC145245, anticorps C80750, anticorps myocyte enhancer factor 2D, anticorps MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D), anticorps mef2d, anticorps MEF2D, anticorps Mef2d

Sujet: MEF2D (Myocyte-specific enhancer factor 2D) is a transcriptional activator which binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific, growth factor- and stress-induced genes. MEF2D mediates cellular functions not only in skeletal and cardiac muscle development, but also in neuronal differentiation and survival. MEF2D plays diverse roles in the control of cell growth, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription. MEF2D plays a critical role in the regulation of neuronal apoptosis (By similarity). MEF2D forms a complex with class II HDACs in undifferentiating cells. On myogenic differentiation, HDACs are released into the cytoplasm allowing MEF2s to interact with other proteins for activation. Interacts with HDAC4 (in undifferentiating cells), the interaction translocates MEF2D to nuclear dots. Forms a heterodimer with MEF2A. Phosphorylated on Ser-444 by CDK5 is required for Lys-439 sumoylation and inhibits transcriptional activity. In neurons, enhanced CDK5 activity induced by neurotoxins promotes caspase 3-mediated cleavage leading to neuron apoptosis. Phsophorylation on Ser-180 can be enhanced by EGF.